BioArctic AB Cash Flow Statement

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	1,022	-177.08	229.25	-11.18	-119.79
Depreciation & Amortization	15.21	13.67	7.44	14.08	13.05
Stock-Based Compensation	24.04	19.33	16.14	2.76	1.57
Other Operating Activities	195.27	-24.35	43.72	-62.21	-30.22
Change in Accounts Receivable	-64.77	-190.56	-11.98	-2.41	-5.12
Change in Other Net Operating Assets	238.99	42.66	25.13	27.33	0.06
Operating Cash Flow	1,431	-316.33	309.69	-31.64	-140.46
Capital Expenditures	-10.24	-26.64	-7.44	-12.75	-4.39
Investment in Securities	-884.4	232.27	-500.04	-0.02	-0.03
Other Investing Activities	-	0	-	0	0
Investing Cash Flow	-894.65	205.63	-507.49	-12.76	-4.41
Long-Term Debt Issued	0.89	-	-	-	-
Long-Term Debt Repaid	-	-0.33	-0.92	-8.79	-7.39
Net Debt Issued (Repaid)	0.89	-0.33	-0.92	-8.79	-7.39
Issuance of Common Stock	26.01	6.02	14.98	5.99	-
Other Financing Activities	-	-0	-0	-	-
Financing Cash Flow	26.9	5.69	14.06	-2.81	-7.39
Foreign Exchange Rate Adjustments	-35.82	6.37	-10.09	4.19	0.72
Miscellaneous Cash Flow Adjustments	-	-0	-	-0	-
Net Cash Flow	527.5	-98.64	-193.82	-43.02	-151.54
Free Cash Flow	1,421	-342.97	302.25	-44.38	-144.84
Free Cash Flow Margin	71.07%	-133.27%	49.07%	-19.35%	-564.40%
Free Cash Flow Per Share	16.01	-3.87	3.42	-0.50	-1.65
Cash Interest Paid	2.35	1.85	0.38	0.75	0.98
Cash Income Tax Paid	71.6	0.52	-0.16	-0.34	0.31
Levered Free Cash Flow	1,161	-287.35	210.92	-34.44	-91.07
Unlevered Free Cash Flow	1,162	-287.35	211.13	-34.09	-90.55
Change in Working Capital	174.22	-147.91	13.15	24.91	-5.06

Source: S&P Global Market Intelligence. Standard template. Financial Sources.